<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02346409</url>
  </required_header>
  <id_info>
    <org_study_id>C14-44</org_study_id>
    <secondary_id>2014-A01393-44</secondary_id>
    <nct_id>NCT02346409</nct_id>
  </id_info>
  <brief_title>Cerebello-thalamo-cortical Coupling in Essential Tremor</brief_title>
  <acronym>CERESTIM</acronym>
  <official_title>Cerebello-thalamo-cortical Coupling in Essential Tremor: Effects of High Frequency tACS of the Cerebellum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut National de la Santé Et de la Recherche Médicale, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Essential tremor (ET) is a frequent and disabling disorder with progressive worsening of
      postural tremor of the upper limbs that impairs most of the manual activities of every day
      life (feeding, drinking, etc.). Although the pathophysiology of essential tremor (ET) is not
      fully elucidated, tremor is associated with abnormal activity within different brain regions,
      in particular the thalamus and the cerebellum. Deep brain stimulation (DBS) of the ventral
      intermediate nucleus of the thalamus (VIM-Thal) reverses the symptoms of tremor but is an
      invasive procedure. Transcranial stimulation of the cerebellum may represent a non-invasive
      therapeutic option for ET patients. Here, the investigators propose to test the efficacy of
      cerebellar stimulation in 15 ET patients previously operated for DBS of the thalamus. To
      further understand how this treatment provokes tremor reduction, the investigators will
      analyse the brain neuronal activity in 13 others ET patients candidate to thalamic DBS by
      using combined electrophysiological recordings of the thalamus (with the electrodes
      implanted), the cerebellum and the cortex with magnetoencephalography.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 4, 2015</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The neuronal activity in the cerebello-thalamo-cortical pathway</measure>
    <time_frame>1 day</time_frame>
    <description>LFP, MEG and EMG activity recordings</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Essential Tremor</condition>
  <arm_group>
    <arm_group_label>LFP-MEG recording with tACS of the cerebellum</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>To explore how cerebellar stimulation (using tACS) will alter oscillations and coupling along the CTC pathway, relating these changes in brain activity to clinical improvement.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tACS of the cerebellum vs VIM-DBS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>To evaluate the differential effects of non invasive high-frequency stimulation tACS of the cerebellum, as compared to high-frequency stimulation of the thalamus (using DBS of the VIM).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>tACS of the cerebellum</intervention_name>
    <description>tACS of the cerebellum</description>
    <arm_group_label>LFP-MEG recording with tACS of the cerebellum</arm_group_label>
    <arm_group_label>tACS of the cerebellum vs VIM-DBS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age below 75 years

          -  diagnosis of essential tremor according to the criteria of the Tremor Investigation
             Group and the Consensus statement of the Movement Disorder Society Group (ref)

          -  health insurance

          -  signed informed written consent

        Exclusion Criteria:

          -  other neurological disorders

          -  medications that interact with or influence brain excitability

          -  significant brain lesions detected in MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marie-Laure Welter</last_name>
    <phone>+33142162461</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jean-Charles Lamy</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>ICM</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marie-Laure Welter</last_name>
      <phone>+33142162461</phone>
    </contact>
    <contact_backup>
      <last_name>Jean-Charles Lamy</last_name>
      <phone>+33142165772</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 5, 2015</study_first_submitted>
  <study_first_submitted_qc>January 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2015</study_first_posted>
  <last_update_submitted>August 29, 2017</last_update_submitted>
  <last_update_submitted_qc>August 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tremor</mesh_term>
    <mesh_term>Essential Tremor</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

